{"text": "we reported fourth quarter and full-year financial results. key fy accomplishments: inflammation acquisition, oncology collaboration in china, 1st u.s. biosimilar launches, 8 straight quarters of volume-driven growth. press release: URL $amgn URL"}
{"text": "$amgn amgen, afterhours 1min URL"}
{"text": "amgen\u2019s $amgn \u201chold\u201d rating reiterated at mizuho URL #stocks"}
{"text": "$amgn #biosimilar revenues of $568m, $biib of $738m and $pfe of $911m in 2019; looks like biosimilars are becoming material to the top line. but for each company it is a portfolio of products and us and europe."}
